Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sigma's Mission miRNA Inhibitors

Premium

Sigma Life Sciences has introduced Mission synthetic and lentiviral microRNA inhibitors for the long-term suppression of any endogenous human and mouse miRNA.

According to the company, the inhibitors are based on tough decoys, which are double-stranded RNAs with a stem-loop stabilized secondary structure, which helps prevent cellular nuclease degradation and enables sustained miRNA inhibition for over one month.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.